Literature DB >> 25758202

How to prevent alcoholic liver disease.

S W French1.   

Abstract

Betaine supplements of alcoholic beverages are proposed to prevent the development of alcoholic liver disease in patients that abuse alcohol. This recommendation is based on the observation of studies where it has been shown in binge drinking and chronic ethanol feeding animal models that betaine prevents liver injury resulting from high blood alcohol levels. The basic observation is that betaine added to ethanol being ingested increases the elimination rate of blood alcohol, which prevents the blood alcohol levels (BALs) from reaching high levels. The mechanism of how betaine does this is postulated to be that betaine causes the increase in the elimination rate by increasing the metabolic rate which generates NAD the rate limiting cofactor of alcohol oxidation by ADH. Betaine does this most likely by supporting the methylation of norepinephrine to form epinephrine by phenylethanolamine N-methyltransferase. Epinephrine is 5 to 10-fold more active than norepinephrine in increasing the metabolic rate.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Betaine; Blood alcohol; Blood alcohol elimination rate; Epinephrine; Generates NAD(+); Metabolic rate

Mesh:

Substances:

Year:  2015        PMID: 25758202      PMCID: PMC4388812          DOI: 10.1016/j.yexmp.2015.03.007

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  23 in total

1.  S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial.

Authors:  Valentina Medici; Maria C Virata; Janet M Peerson; Sally P Stabler; Samuel W French; Jesse F Gregory; Anthony Albanese; Christopher L Bowlus; Sridevi Devaraj; Edward A Panacek; John R Richards; Charles H Halsted
Journal:  Alcohol Clin Exp Res       Date:  2011-11       Impact factor: 3.455

2.  Betaine feeding prevents the blood alcohol cycle in rats fed alcohol continuously for 1 month using the rat intragastric tube feeding model.

Authors:  J Li; X M Li; M Caudill; O Malysheva; F Bardag-Gorce; J Oliva; B A French; E Gorce; K Morgan; E Kathirvel; T Morgan; S W French
Journal:  Exp Mol Pathol       Date:  2011-06-25       Impact factor: 3.362

3.  Alcoholic liver disease patients treated with S-adenosyl-L-methionine: an in-depth look at liver morphologic data comparing pre and post treatment liver biopsies.

Authors:  Mary D Le; Elena Enbom; Peter K Traum; Valentina Medici; Charles H Halsted; Samuel W French
Journal:  Exp Mol Pathol       Date:  2013-07-23       Impact factor: 3.362

4.  The effect of rotenone on the urinary ethanol cycle in rats fed ethanol intragastrically.

Authors:  J Li; P Fu; B A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2004-12       Impact factor: 3.362

5.  The cyclic pattern of blood alcohol levels during continuous ethanol feeding in rats: the effect of feeding S-adenosylmethionine.

Authors:  F Bardag-Gorce; J Li; J Oliva; S C Lu; B A French; S W French
Journal:  Exp Mol Pathol       Date:  2010-03-17       Impact factor: 3.362

6.  Role of hormones in the mechanism of the swift increase in alcohol metabolism in the rat.

Authors:  T Yuki; B U Bradford; R G Thurman
Journal:  Pharmacol Biochem Behav       Date:  1980       Impact factor: 3.533

7.  The effects of betaine treatment on rats fed an acute bolus of ethanol at 3 and 12 h post bolus: a microarray analysis.

Authors:  J Li; F Bardag-Gorce; J Oliva; B A French; J Dedes; S W French
Journal:  Genes Nutr       Date:  2010-03-19       Impact factor: 5.523

8.  Catecholamines are involved in the mechanism of the urinary alcohol level cycle in rats fed ethanol intragastrically at a constant rate.

Authors:  Jun Li; Barbara A French; Paul Fu; Fawzia Bardag-Gorce; Samuel W French
Journal:  Life Sci       Date:  2004-11-05       Impact factor: 5.037

9.  Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial.

Authors:  Manal F Abdelmalek; Schuyler O Sanderson; Paul Angulo; Consuelo Soldevila-Pico; Chen Liu; Joy Peter; Jill Keach; Matt Cave; Theresa Chen; Craig J McClain; Keith D Lindor
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

Review 10.  The global burden of liver disease: the major impact of China.

Authors:  Fu-Sheng Wang; Jian-Gao Fan; Zheng Zhang; Bin Gao; Hong-Yang Wang
Journal:  Hepatology       Date:  2014-10-29       Impact factor: 17.425

View more
  4 in total

1.  Over expression of proteins that alter the intracellular signaling pathways in the cytoplasm of the liver cells forming Mallory-Denk bodies.

Authors:  N Afifiyan; B Tillman; B A French; M Masouminia; S Samadzadeh; S W French
Journal:  Exp Mol Pathol       Date:  2017-01-13       Impact factor: 3.362

Review 2.  Role of betaine in liver disease-worth revisiting or has the die been cast?

Authors:  Sandeep Mukherjee
Journal:  World J Gastroenterol       Date:  2020-10-14       Impact factor: 5.742

Review 3.  Betaine in ameliorating alcohol-induced hepatic steatosis.

Authors:  Aisha Rehman; Kosha J Mehta
Journal:  Eur J Nutr       Date:  2021-11-24       Impact factor: 5.614

4.  Effect of Folic Acid, Betaine, Vitamin B₆, and Vitamin B12 on Homocysteine and Dimethylglycine Levels in Middle-Aged Men Drinking White Wine.

Authors:  Daniel Rajdl; Jaroslav Racek; Ladislav Trefil; Pavel Stehlik; Jana Dobra; Vaclav Babuska
Journal:  Nutrients       Date:  2016-01-12       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.